In the CTEPH group, both NLR and serum albumin demonstrated very good prognostic performance for predicting 3-month all-cause mortality, with AUCs of 0.875 and 0.833, respectively. The gene discussed is ALB; the disease is chronic thromboembolic pulmonary hypertension.